Qi‐Dong Xia

1.9k total citations
99 papers, 1.2k citations indexed

About

Qi‐Dong Xia is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Qi‐Dong Xia has authored 99 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 41 papers in Pulmonary and Respiratory Medicine and 26 papers in Surgery. Recurrent topics in Qi‐Dong Xia's work include Bladder and Urothelial Cancer Treatments (21 papers), Ferroptosis and cancer prognosis (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Qi‐Dong Xia is often cited by papers focused on Bladder and Urothelial Cancer Treatments (21 papers), Ferroptosis and cancer prognosis (15 papers) and Cancer, Lipids, and Metabolism (13 papers). Qi‐Dong Xia collaborates with scholars based in China and United States. Qi‐Dong Xia's co-authors include Shaogang Wang, Jia Hu, Jian‐Xuan Sun, Junlin Lu, Jin‐Zhou Xu, Chen‐Qian Liu, Yang Xun, Cong Li, Shicheng Su and Yuchao Lu and has published in prestigious journals such as Cell, Journal of the American Chemical Society and Nature Cell Biology.

In The Last Decade

Qi‐Dong Xia

86 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi‐Dong Xia China 18 489 328 302 286 251 99 1.2k
Fan Sun China 24 560 1.1× 240 0.7× 539 1.8× 230 0.8× 454 1.8× 69 1.4k
Ying Lv China 24 633 1.3× 384 1.2× 304 1.0× 116 0.4× 329 1.3× 102 1.5k
Jianghong Wu China 23 901 1.8× 193 0.6× 317 1.0× 180 0.6× 379 1.5× 49 1.6k
Yan Zhu China 21 518 1.1× 243 0.7× 399 1.3× 151 0.5× 347 1.4× 69 1.3k
Xue Pan China 20 446 0.9× 253 0.8× 282 0.9× 169 0.6× 192 0.8× 63 1.1k
Jing Kong China 22 807 1.7× 206 0.6× 412 1.4× 192 0.7× 449 1.8× 67 1.6k
Bibo Tan China 22 790 1.6× 290 0.9× 255 0.8× 160 0.6× 558 2.2× 103 1.4k
Tadashi Uwagawa Japan 17 521 1.1× 127 0.4× 482 1.6× 244 0.9× 363 1.4× 42 1.2k
Shigefumi Yoshino Japan 29 652 1.3× 349 1.1× 836 2.8× 568 2.0× 288 1.1× 114 1.9k
Junmin Zhou United States 19 539 1.1× 115 0.4× 447 1.5× 528 1.8× 270 1.1× 55 1.5k

Countries citing papers authored by Qi‐Dong Xia

Since Specialization
Citations

This map shows the geographic impact of Qi‐Dong Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi‐Dong Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi‐Dong Xia more than expected).

Fields of papers citing papers by Qi‐Dong Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi‐Dong Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi‐Dong Xia. The network helps show where Qi‐Dong Xia may publish in the future.

Co-authorship network of co-authors of Qi‐Dong Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Qi‐Dong Xia. A scholar is included among the top collaborators of Qi‐Dong Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi‐Dong Xia. Qi‐Dong Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jian‐Xuan, Qi‐Dong Xia, Jin‐Zhou Xu, et al.. (2025). A novel prostate cancer-specific fluorescent probe based on extracellular vesicles targeting STEAP1 applied in fluorescence guided surgery. Journal of Controlled Release. 380. 199–218. 2 indexed citations
2.
Xu, Jin‐Zhou, et al.. (2025). Mechanisms of Oncolytic Virus-Induced Multi-Modal Cell Death and Therapeutic Prospects. International Journal of Molecular Sciences. 26(19). 9770–9770.
3.
Xiong, Yifan, et al.. (2025). A Highly Sensitive Methylation Assay for Prostate Cancer Diagnosis. The World Journal of Men s Health. 44(1). 118–118.
5.
Xia, Qi‐Dong, Jian‐Xuan Sun, Zhipeng Yao, et al.. (2024). The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG. npj Precision Oncology. 8(1). 216–216. 2 indexed citations
6.
Xia, Qi‐Dong, Chuqiao Li, Ming‐Yang Wang, et al.. (2024). Bench-Stable Meisenheimer Complexes: Synthesis, Characterization, and Divergent Reactivity for Dearomatization. Journal of the American Chemical Society. 146(45). 30764–30770. 4 indexed citations
7.
Sun, Jian‐Xuan, et al.. (2024). Trends in focal therapy for localized prostate cancer: a bibliometric analysis from 2014 to 2023. Discover Oncology. 15(1). 472–472.
10.
Li, Jiang, Qi‐Dong Xia, Can Di, et al.. (2023). Tumor Cell‐Intrinsic CD96 Mediates Chemoresistance and Cancer Stemness by Regulating Mitochondrial Fatty Acid β‐Oxidation (Adv. Sci. 7/2023). Advanced Science. 10(7). 1 indexed citations
11.
Liu, Huan, Yuanpeng Zhang, Qi‐Dong Xia, et al.. (2023). Triplex-structure based DNA circuits with ultra-low leakage and high signal-to-noise ratio. Chinese Chemical Letters. 35(1). 108555–108555. 4 indexed citations
12.
Sun, Jian‐Xuan, Chen‐Qian Liu, Qi‐Dong Xia, et al.. (2023). A Novel Predictive Model of Pathological Lymph Node Metastasis Constructed with Preoperative Independent Predictors in Patients with Renal Cell Carcinoma. Journal of Clinical Medicine. 12(2). 441–441. 3 indexed citations
13.
Sun, Jian‐Xuan, Chen‐Qian Liu, Jin‐Zhou Xu, et al.. (2023). Pan-cancer analysis reveals the prognostic and immunologic roles of cereblon and its significance for PROTAC design. Heliyon. 9(6). e16644–e16644. 2 indexed citations
14.
Sun, Jian‐Xuan, et al.. (2023). Unveiling the Association between HPV and Pan-Cancers: A Bidirectional Two-Sample Mendelian Randomization Study. Cancers. 15(21). 5147–5147. 11 indexed citations
15.
Sun, Jian‐Xuan, et al.. (2023). The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer Treatment. International Journal of Molecular Sciences. 24(17). 13603–13603. 8 indexed citations
16.
Xia, Qi‐Dong, Jian‐Xuan Sun, Chen‐Qian Liu, et al.. (2022). Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer. Frontiers in Cell and Developmental Biology. 10. 832892–832892. 22 indexed citations
17.
Sun, Jian‐Xuan, Jin‐Zhou Xu, Chen‐Qian Liu, et al.. (2022). The association between human papillomavirus and bladder cancer: Evidence from meta‐analysis and two‐sample mendelian randomization. Journal of Medical Virology. 95(1). e28208–e28208. 39 indexed citations
18.
Sun, Jian‐Xuan, Mengyao Xu, Chen‐Qian Liu, et al.. (2022). Statin Use Is Associated with Better Prognosis of Patients with Prostate Cancer after Definite Therapies: A Systematic Review and Meta-Analysis of Cohort Studies. Journal of Oncology. 2022. 1–10. 9 indexed citations
19.
Xia, Qi‐Dong, Yuan Zhang, Lisha Li, et al.. (2022). Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma. Disease Markers. 2022. 1–18. 6 indexed citations
20.
Xu, Mengyao, Chen‐Qian Liu, Jin‐Zhou Xu, et al.. (2022). Association of Statin Use with the Risk of Incident Prostate Cancer: A Meta-Analysis and Systematic Review. Journal of Oncology. 2022. 1–13. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026